Category: Lung Cancer

Source: Utility of WT-1, p63, MOC31, Mesothelin, and Cytokeratin (K903 and CK5/6) Immunostains in Differentiating Adenocarcinoma, Squamous Cell Carcinoma, and (Diagn Cytopathol. 2008 Jan;36(1):20-5) The first step in a diagnosis of cancer is the definitive conclusion of the presence of malignant tissue. However, this tissue may not identify the particular form of cancer at work, …

Source: Australasian Radiology One of the most difficult aspects of treating cancer is the distinct number of forms it can take. While most cancers follow particular biological patterns, the literature is full of examples that do not follow these general trends. For example, in patients who present with a number of different tumors, metastasis is …

Source: Occupational and Environmental Medicine Asbestos exposure is a constant concern for workers in shipyards. There is evidence to suggest that these workers are much more likely to come down with an asbestos-related disease than other professions. A study looking at the health patterns of a group of 4702 workers of a Coast Guard shipyard …

Source: Eli Lilly Eli Lilly has submitted an application with the European Medicines Agency (EMEA) for the approval of Alimta®, in combination with cisplatin, as a first-line treatment for advanced non-small cell lung cancer (NSCLC). The EMEA has previously approved Alimta as a single agent, second-line therapy for advanced NSCLC. The submission is based on …

Source: Wall Street Journal In a supplement published in the medical journal Chest, the American College of Chest Physicians offered the first comprehensive analysis on the use of alternative and complementary medicine in the treatment of lung cancer. The researchers examined over 100 published studies regarding alternative or complementary medicine in an attempt to quantify …

Source: World Health Organization The World Health Organization is calling on governments to enact meaningful reform to workplace safety laws and to increase the measures used to protect workers from work-related injury or death. At least 200,000 people die every year from work-caused cancers and millions more are regularly exposed to carcinogenic agents that can …

Source: News-Medical.Net Researches from the Ireland Cancer Center have discovered a mutation in the epidermal growth factor protein (EGFR) that causes resistance in lung cancer cells to targeting agents, such as Tarceva, that attempt to halt the spread of cancer cells by disrupting the receptor responsible for tumor growth. Tarceva has been successfully deployed in …

Source: Rosetta Genomics The NYU Medical Center, one of the world’s premier academic medical institutions, has partnered with Rosetta Genomics, a leader in the development of microRNA-based diagnostics and therapeutics, to jointly-develop early detection diagnostic tools for lung cancer and mesothelioma. Dr. Harvey Pass, Professor and Chief of the Division of Thoracic Surgery and Thoracic …

Source: Billings Gazette Libby, Montana is the location of what the EPA calls “the worst case of community-wide exposure to a toxic substance in U.S. history.” One of Libby’s major revenue sources was its vermiculite mine, but in 1990 it was discovered that the mine was contaminated with asbestos and that this contamination had exposed …

Source: ScrippsNews The Utah Department of Health has concluded that people who lived within two miles of two old vermiculite plants with heavy asbestos contamination in Salt Lake City have a fifty percent greater chance of developing lung cancer than people who live in other parts of the state. While the data didn’t conclusively establish …